Key facts
- It has raised $290K; the latest was Seed Round ($120K) in Jul 2025.
- Notable investors include Enterprise Ireland.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Nazata Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Nazata Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nazata Bio
Developer and operator of a digital therapeutic app intended for blood pressure management. The company's platform functions as a specialist dietitian, an exercise coach, and a behavioral scientist, offering treatment plans and a personalization algorithm that adapts to individual needs, enabling patients worldwide to better manage high blood pressure through lifestyle changes, improved monitoring, and evidence-based behavioral support.
- Sector
- Healthcare
- HQ
- Navan, Ireland
- Employees
- 4
- Website
- nazatabio.com/
- Ownership
- Privately Held (backing)
Nazata Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nazata Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nazata Bio in its N-PORT filings yet. We sweep new filings monthly.